{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T02:43:54Z","timestamp":1774579434825,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":653,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.repc.2016.10.009","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T15:47:22Z","timestamp":1499528842000},"page":"569.e1-569.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["VIH e doen\u00e7a coron\u00e1ria \u2013 quando a preven\u00e7\u00e3o secund\u00e1ria \u00e9 insuficiente"],"prefix":"10.1016","volume":"36","author":[{"given":"Ana Sofia","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Os\u00f3rio Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Almeida Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Modas Daniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramiro","family":"S\u00e1 Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lurdes","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Cruz Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2016.10.009_bib0175","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bjid.2013.05.004","article-title":"A literature review on cardiovascular risk in human immunodeficiency virus\u2010infected patients: implications for clinical management","volume":"17","author":"Neto","year":"2013","journal-title":"Braz J Infect Dis."},{"key":"10.1016\/j.repc.2016.10.009_bib0180","doi-asserted-by":"crossref","first-page":"e000174","DOI":"10.1136\/openhrt-2014-000174","article-title":"Cardiovascular disease in HIV patients: from bench to bedside and backwards","volume":"2","author":"Cerrato","year":"2015","journal-title":"Open Heart."},{"key":"10.1016\/j.repc.2016.10.009_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2014.04.155","article-title":"Cardiovascular disease in patients with chronic human immunodeficiency virus infection","volume":"175","author":"Esc\u00e1rcega","year":"2014","journal-title":"Int J Cardiol."},{"key":"10.1016\/j.repc.2016.10.009_bib0190","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/QAD.0b013e32833a0918","article-title":"Factors associated with specific causes of death amongst HIV\u2010positive individuals in the D:A:D Study","volume":"24","author":"Smith","year":"2010","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2016.10.009_bib0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.repc.2016.10.009_bib0200","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV\u20101\u2014infected patients treated with antiretroviral therapy, 1996\u20102006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2016.10.009_bib0205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet."},{"key":"10.1016\/j.repc.2016.10.009_bib0210","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Trian","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.repc.2016.10.009_bib0215","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.repc.2016.10.009_bib0220","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/hrt.2005.068445","article-title":"Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis","volume":"92","author":"Boccara","year":"2006","journal-title":"Heart."},{"key":"10.1016\/j.repc.2016.10.009_bib0225","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/CIRCULATIONAHA.113.001874","article-title":"Outcomes after acute myocardial infarction in HIV\u2010infected patients: analysis of data from a French nationwide hospital medical information database","volume":"127","author":"Lorgis","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.repc.2016.10.009_bib0230","first-page":"192","article-title":"Safety and long\u2010term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virus","volume":"85","author":"Badr","year":"2015","journal-title":"Catheter Cardiovasc Interv."},{"key":"10.1016\/j.repc.2016.10.009_bib0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1468-1293.2006.00400.x","article-title":"Prevalence of risk factors for cardiovascular disease in HIV\u2010infected patients over time: The Swiss HIV Cohort Study","volume":"7","author":"Glass","year":"2006","journal-title":"HIV Med."},{"key":"10.1016\/j.repc.2016.10.009_bib0240","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients\u2013association with antiretroviral therapy. Results from the DAD study","volume":"17","author":"Friis-M\u00f8ller","year":"2003","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2016.10.009_bib0245","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.repc.2016.10.009_bib0250","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.repc.2016.10.009_bib0255","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1161\/CIRCULATIONAHA.105.546465","article-title":"What a cardiologist needs to know about patients with human immunodeficiency virus infection","volume":"112","author":"Hsue","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.repc.2016.10.009_bib0260","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1473-3099(07)70287-6","article-title":"HIV\u2010associated dyslipidaemia: pathogenesis and treatment","volume":"7","author":"Oh","year":"2007","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.repc.2016.10.009_bib0265","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev."},{"key":"10.1016\/j.repc.2016.10.009_bib0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.atherosclerosis.2015.03.019","article-title":"High prevalence at computed coronary tomography of non\u2010calcified plaques in asymptomatic HIV patients treated with HAART: a meta\u2010analysis","volume":"240","author":"D\u2019Ascenzo","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.repc.2016.10.009_bib0275","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV\u20101 protease\u2010inhibitor\u2010associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet."},{"key":"10.1016\/j.repc.2016.10.009_bib0280","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00002030-200304001-00017","article-title":"HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management","volume":"17","author":"Carr","year":"2003","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2016.10.009_bib0285","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jinf.2008.02.006","article-title":"Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy","volume":"57","author":"Calza","year":"2008","journal-title":"J Infect."},{"key":"10.1016\/j.repc.2016.10.009_bib0290","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti\u2010HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis."},{"key":"10.1016\/j.repc.2016.10.009_bib0295","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/QAD.0b013e328347fa16","article-title":"Cardiovascular risks associated with abacavir and tenofovir exposure in HIV\u2010infected persons","volume":"25","author":"Choi","year":"2011","journal-title":"AIDS."},{"key":"10.1016\/j.repc.2016.10.009_bib0300","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/ciq244","article-title":"No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: Short and long\u2010term results from ACTG A5001\/ALLRT","volume":"52","author":"Ribaudo","year":"2011","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.repc.2016.10.009_bib0305","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/QAI.0b013e31819ff0e6","article-title":"Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline\u2010sponsored clinical trials in adult subjects","volume":"51","author":"Brothers","year":"2009","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1016\/j.repc.2016.10.009_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-016-0588-4","article-title":"Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration","volume":"14","author":"Sabin","year":"2016","journal-title":"BMC Med."},{"key":"10.1016\/j.repc.2016.10.009_bib0315","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amjcard.2012.05.045","article-title":"Comparison of in\u2010hospital mortality from acute myocardial infarction in HIV sero\u2010positive versus sero\u2010negative individuals","volume":"110","author":"Pearce","year":"2012","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.repc.2016.10.009_bib0320","first-page":"879","article-title":"Outcome of percutaneous coronary intervention in HIV\u2010infected patients","volume":"68","author":"Segev","year":"2006","journal-title":"Catheter Cardiovasc Interv."},{"key":"10.1016\/j.repc.2016.10.009_bib0325","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.07.030","article-title":"Cardiovascular disease in HIV infection","volume":"151","author":"Sudano","year":"2006","journal-title":"Am Heart J."},{"key":"10.1016\/j.repc.2016.10.009_bib0330","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.repc.2016.10.009_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-6405-7-9","article-title":"Markers of inflammation and coagulation indicate a prothrombotic state in HIV\u2010infected patients with long\u2010term use of antiretroviral therapy with or without abacavir","volume":"7","author":"Jong","year":"2010","journal-title":"AIDS Res Ther."},{"key":"10.1016\/j.repc.2016.10.009_bib0340","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/107602960401000311","article-title":"Thrombosis and a hypercoagulable state in HIV\u2010infected patients","volume":"10","author":"Shen","year":"2004","journal-title":"Clin Appl Thromb."}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S087025511730286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S087025511730286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:05:19Z","timestamp":1760108719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S087025511730286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":34,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S087025511730286X"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2016.10.009","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VIH e doen\u00e7a coron\u00e1ria \u2013 quando a preven\u00e7\u00e3o secund\u00e1ria \u00e9 insuficiente","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2016.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}